Georgia's Online Cancer Information Center

Anal Cancer Clinical Trials in Georgia

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.
Cancer Type = Anal Cancer
Cancer Type = Anal Cancer
There are currently 2 active Anal Cancer clinical trials in Georgia.
1.
EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients
Cancer Type
Anal Cancer, Unknown Primary
NCT ID
NCT04444921
Protocol IDs
EA2176
EA2176
NCI-2020-04334
2.
Imiquimod, Fluorouracil, or Observation in Treating Patients with High-Grade Anal Squamous Skin Lesions Who Are HIV-Positive
Cancer Type
Anal Cancer, Unknown Primary
NCT ID
NCT02059499
Protocol IDs
AMC-088
NCI-2013-02288
AMC-088
Treatment Sites (1)
Georgia Cancer Center for Excellence at Grady
Atlanta
Scott Edelman
404-489-9000
Georgia CORE

 

Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a statewide nonprofit that leverages partnerships and innovation to attract more clinical trials, increase research, and promote education and early detection to improve cancer care for Georgians in rural, urban, and suburban communities across the state.